Lead Author, Publication Date
|
Infective organisms reported (%)
|
Chiu et al. 2007,[@112019] |
Coagulase negative staphylococcus (40%)
MRSA (30%)
S. beta haemoliticus (10%)
S. aureus (10%)
Candida parapsilosis (10%)
|
Choi et al. 2011,[@112024] |
S. aureus (33%)
Coagulase-negative Staphylococcus (26%)
Streptococcus spp. (10%)
Others (17%)
Polybacterial (10%)
|
Estes et al. 2010,[@112006] |
MSSA (27%)
MRSA (9%)
Coagulase Negative Staphylococcus (9%)
Streptococcus spp (36%)
Polymicrobial (1%)
E. coli (18%)
|
Fink et al. 2017,[@112023] |
S. aureus (25 %)
MSSE (14%)
MRSE (4%)
Streptococcus spp. (14%)
Others (22%)
|
He et al. 2016,[@112003] |
Staphylococcus spp. (18%)
Streptococcus spp. (63%)
Others (18%)
|
In jun Koh et al. 2015,[@112025] |
Culture negative (19%)
Staphyloccus spp. (42%)
Others (39%)
|
Konigsberg et al. 2014,[@112012] |
Streptococcus spp. (75%)
Staphylococcus spp. (40%)
Others (12%)
Polymicrobial (5%)
No growth (5%)
|
Koyonos et al. 2011,[@112013] |
MRSA (12%)
Culture-negative (16%)
Staphylococcus spp. (40%)
|
Lora-Tamayo et al. 2017,[@112014] |
Streptococcus spp. 100% |
Meehan et al. 2003,[@112015] |
Streptococcus spp. 100% |
Mont et al. 1997,[@112016] |
S. aureus (64%)
S. epidermidis ((21%)
E. coli (14%)
|
Segawa et al. 1999,[@112017] |
Coagulase-positive staphylococci (22%)
Coagulase-negative staphylococci (22%)
Streptococcus spp. (44%)
Enterococcus spp. (11%)
|
Son et al. 2017,[@112018] |
MRSA
MRSE
Imipenem resistant Acinetobacter baumanii
MSSA
Streptococcus spp.
Polymicrobial
|
Triantafyllopoulos et al. 2014,[@111996] |
MRSA (27%)
MSSA (41%)
Other gram-positive bacteria (10%)
Gram negative bacteria (7%)
Negative cultures (11%)
|
Vilchez et al. 2011,[@112020] |
MRSA (20%)
Staphylococcus aureus resistant to fluoroquinolones (80%)
|
Zhang et al. 2016,[@111997] |
Staphylococcus spp. (64%)
Nonstaphylococcal spp (36%):
S. enteriditis;
S. dysgalactiae;
P. acnes;
P. aeruginosa;
E. coli
|